Anti-CTLA4 Monoclonal Antibody Induced Sarcoidosis in a Metastatic Melanoma Patient

Publisher： Karger

E-ISSN： 1421-9832|218|1|69-70

ISSN： 1018-8665

Source： Dermatology, Vol.218, Iss.1, 2008-10, pp. : 69-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Flare-Up of Rheumatoid Arthritis by Anti-CTLA-4 Antibody but Not by Anti-PD1 Therapy in a Patient with Metastatic Melanoma

By  

Case Reports in Dermatology, Vol. 9, Iss. 1, 2017-03 ,pp. : 65-68

Karger

Access to resources Recommend Favorite

Sarcoidosis in Patients Treated with Vemurafenib for Metastatic Melanoma: A Paradoxical Autoimmune Activation

By  

Dermatology, Vol. 231, Iss. 4, 2015-0 ,pp. : 378-384

Karger

Access to resources Recommend Favorite

Treatment of Refractory Pemphigus with the Anti-CD20 Monoclonal Antibody (Rituximab)

By  

Dermatology, Vol. 214, Iss. 4, 2007-04 ,pp. : 310-318

Karger

Access to resources Recommend Favorite

Rituximab (Anti-CD20 Monoclonal Antibody) – Ultimate or First Choice in Pemphigus?

By  

Dermatology, Vol. 214, Iss. 4, 2007-04 ,pp. : 275-277

Karger

Access to resources Recommend Favorite

Adverse Skin Reactions to Anti-TNF-Alpha Monoclonal Antibody Therapy

By  

Dermatology, Vol. 206, Iss. 4, 2003-06 ,pp. : 388-390

Karger

Access to resources Recommend Favorite